Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1994 Sep;220(3):320–330. doi: 10.1097/00000658-199409000-00008

Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma.

D L Fraker 1, J A Norton 1, H R Alexander 1, D J Venzon 1, R T Jensen 1
PMCID: PMC1234386  PMID: 7916560

Abstract

OBJECTIVE: The authors assessed the impact of gastrinoma resection on the subsequent development of hepatic metastases in Zollinger-Ellison syndrome. SUMMARY BACKGROUND DATA: The symptoms of acid hypersecretion can be controlled medically in Zollinger-Ellison syndrome with high-dose pharmacologic therapy. The current role of surgery is curative excision of the gastrinoma. Because biochemical cure is obtained only in a portion of the patients and the neoplastic disease may be indolent in this syndrome, the ability of surgical resection of gastrinoma to alter or improve the subsequent development of hepatic metastases and mortality has not been defined. METHODS: One hundred twenty-four patients with the biochemical diagnosis of Zollinger-Ellison syndrome and no hepatic metastases on initial imaging studies were evaluated. Ninety-eight patients underwent surgical exploration for curative gastrinoma resections while 26 patients were managed medically. Long-term follow-up regarding development of hepatic metastases and survival were evaluated. RESULTS: Surgical exploration with gastrinoma excision resulted in a significantly decreased incidence of hepatic metastases 3% (3/98) compared with patients managed medically 23% (6/26) with comparable follow-up (p < 0.003). Two deaths due to metastatic gastrinoma occurred in the nonoperative group compared with no disease-specific deaths in the surgical group (p = 0.085). CONCLUSIONS: For the patient with Zollinger-Ellison syndrome without metastatic disease, surgical exploration with attempted curative gastrinoma resection is recommended because it may alter the natural history of this syndrome.

Full text

PDF
320

Images in this article

324Figure 1.
on p.324
325Figure 3.
on p.325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Delcore R., Jr, Cheung L. Y., Friesen S. R. Characteristics of duodenal wall gastrinomas. Am J Surg. 1990 Dec;160(6):621–624. doi: 10.1016/s0002-9610(05)80760-3. [DOI] [PubMed] [Google Scholar]
  2. Ellison E. C., Carey L. C., Sparks J., O'Dorisio T. M., Mekhjian H. S., Fromkes J. J., Caldwell J. H., Thomas F. B. Early surgical treatment of gastrinoma. Am J Med. 1987 May 29;82(5B):17–24. doi: 10.1016/0002-9343(87)90423-2. [DOI] [PubMed] [Google Scholar]
  3. Fishbeyn V. A., Norton J. A., Benya R. V., Pisegna J. R., Venzon D. J., Metz D. C., Jensen R. T. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med. 1993 Aug 1;119(3):199–206. doi: 10.7326/0003-4819-119-3-199308010-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fox P. S., Hofmann J. W., Wilson S. D., DeCosse J. J. Surgical management of the Zollinger-Ellison syndrome. Surg Clin North Am. 1974 Apr;54(2):395–407. doi: 10.1016/s0039-6109(16)40287-2. [DOI] [PubMed] [Google Scholar]
  5. Fraker D. L., Norton J. A. Localization and resection of insulinomas and gastrinomas. JAMA. 1988 Jun 24;259(24):3601–3605. [PubMed] [Google Scholar]
  6. Fraker D. L., Norton J. A. The role of surgery in the management of islet cell tumors. Gastroenterol Clin North Am. 1989 Dec;18(4):805–830. [PubMed] [Google Scholar]
  7. Frucht H., Norton J. A., London J. F., Vinayek R., Doppman J. L., Gardner J. D., Jensen R. T., Maton P. N. Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. Gastroenterology. 1990 Dec;99(6):1622–1627. doi: 10.1016/0016-5085(90)90466-e. [DOI] [PubMed] [Google Scholar]
  8. Imamura M., Kanda M., Takahashi K., Shimada Y., Miyahara T., Wagata T., Hashimoto M., Tobe T., Soga J. Clinicopathological characteristics of duodenal microgastrinomas. World J Surg. 1992 Jul-Aug;16(4):703–710. doi: 10.1007/BF02067363. [DOI] [PubMed] [Google Scholar]
  9. Malagelada J. R., Edis A. J., Adson M. A., van Heerden J. A., Go V. L. Medical and surgical options in the management of patients with gastrinoma. Gastroenterology. 1983 Jun;84(6):1524–1532. [PubMed] [Google Scholar]
  10. Maton P. N., Gardner J. D., Jensen R. T. Diagnosis and management of Zollinger-Ellison syndrome. Endocrinol Metab Clin North Am. 1989 Jun;18(2):519–543. [PubMed] [Google Scholar]
  11. Maton P. N., Gardner J. D., Jensen R. T. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterol Clin North Am. 1989 Dec;18(4):847–863. [PubMed] [Google Scholar]
  12. Maton P. N., Miller D. L., Doppman J. L., Collen M. J., Norton J. A., Vinayek R., Slaff J. I., Wank S. A., Gardner J. D., Jensen R. T. Role of selective angiography in the management of patients with Zollinger-Ellison syndrome. Gastroenterology. 1987 Apr;92(4):913–918. doi: 10.1016/0016-5085(87)90964-4. [DOI] [PubMed] [Google Scholar]
  13. McCarthy D. M. The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med. 1980 Jun 12;302(24):1344–1347. doi: 10.1056/NEJM198006123022404. [DOI] [PubMed] [Google Scholar]
  14. Norton J. A., Doppman J. L., Jensen R. T. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg. 1992 Jan;215(1):8–18. doi: 10.1097/00000658-199201000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pipeleers-Marichal M., Somers G., Willems G., Foulis A., Imrie C., Bishop A. E., Polak J. M., Häcki W. H., Stamm B., Heitz P. U. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 1990 Mar 15;322(11):723–727. doi: 10.1056/NEJM199003153221103. [DOI] [PubMed] [Google Scholar]
  16. Sheppard B. C., Norton J. A., Doppman J. L., Maton P. N., Gardner J. D., Jensen R. T. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery. 1989 Dec;106(6):1108–1118. [PubMed] [Google Scholar]
  17. Thom A. K., Norton J. A., Axiotis C. A., Jensen R. T. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery. 1991 Dec;110(6):1086–1093. [PubMed] [Google Scholar]
  18. Thompson J. C., Lewis B. G., Wiener I., Townsend C. M., Jr The role of surgery in the Zollinger-Ellison syndrome. Ann Surg. 1983 May;197(5):594–607. doi: 10.1097/00000658-198305000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thompson N. W., Bondeson A. G., Bondeson L., Vinik A. The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery. 1989 Dec;106(6):1081–1086. [PubMed] [Google Scholar]
  20. Wolfe M. M., Alexander R. W., McGuigan J. E. Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery. N Engl J Med. 1982 Jun 24;306(25):1533–1536. doi: 10.1056/NEJM198206243062506. [DOI] [PubMed] [Google Scholar]
  21. ZOLLINGER R. M., ELLISON E. H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8. [PMC free article] [PubMed] [Google Scholar]
  22. Zollinger R. M., Ellison E. C., O'Dorisio T. M., Sparks J. Thirty years' experience with gastrinoma. World J Surg. 1984 Aug;8(4):427–435. doi: 10.1007/BF01654904. [DOI] [PubMed] [Google Scholar]
  23. Zollinger R. M. Gastrinoma: factors influencing prognosis. Surgery. 1985 Jan;97(1):49–54. [PubMed] [Google Scholar]
  24. van Heerden J. A., Smith S. L., Miller L. J. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I. Surgery. 1986 Dec;100(6):971–977. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES